
![]() |
|||||||||||||
WJPR Citation
|
| All | Since 2020 | |
| Citation | 8502 | 4519 |
| h-index | 30 | 23 |
| i10-index | 227 | 96 |
AYURVEDIC MANAGEMENT OF EPISCLERITIS (SIRAJALA): A CASE STUDY
Dr. Nikhil Nagnath Mali*
Abstract Sirajala, an Ayurvedic condition classified under Shuklagata roga, is analogous to episcleritis in modern medicine, a condition characterized by inflammation of the episcleral tissue. While conventional treatments such as topical NSAIDs and steroids provide symptomatic relief, the condition frequently recurs within 2 to 3 months. This case study explores the effectiveness of Ayurvedic management in treating episcleritis and preventing its recurrence. A 45-year-old female presented with redness, mild pain, and watering in her left eye for four days, having experienced a similar episode two months prior. After receiving conventional treatment, her symptoms recurred, leading her to seek Ayurvedic care. Upon examination, she was diagnosed with diffuse episcleritis (Sirajala). Ayurvedic treatment was initiated using Pathyadi Shadangam Kashayam, Kaishor Guggulu, and Samshamani Vati, all of which have anti-inflammatory and blood-purifying properties. The treatment aimed to address the root cause of the condition, which, according to Ayurvedic principles, originates from the gut and involves vitiated blood (rakta dushti). After 15 days of oral medication, a significant reduction in episcleral congestion and redness was observed, with the patient reporting relief from pain and watering. To prevent recurrence, the treatment was continued for six months, during which no further episodes were noted. This case highlights the potential of Ayurvedic formulations to manage episcleritis effectively, providing both acute symptom relief and long-term prevention of recurrence. Further clinical studies are needed to confirm the broader applicability of these findings. Keywords: Ayurvedic management, Episcleritis, Pathyadi Shadangam Kashaya, Recurrence, Sirajala. [Full Text Article] [Download Certificate] |
